Proposition of decision limits for serum lipids in Brazilian children aged one to 13 years.


Journal

Jornal de pediatria
ISSN: 1678-4782
Titre abrégé: J Pediatr (Rio J)
Pays: Brazil
ID NLM: 2985188R

Informations de publication

Date de publication:
Historique:
received: 11 05 2017
revised: 20 11 2017
accepted: 10 01 2018
pubmed: 13 3 2018
medline: 29 10 2019
entrez: 13 3 2018
Statut: ppublish

Résumé

To determine decision limits for total cholesterol, LDL-cholesterol, non-HDL cholesterol, HDL-cholesterol, and triglycerides in healthy children and adolescents from Cuiabá, Brazil. This was a cross-sectional study of 1866 healthy children and adolescents randomly selected from daycare centers and public schools in Cuiabá. The desirable levels of serum lipids were defined using the classic criteria, i.e., total cholesterol, LDL-cholesterol, non-HDL cholesterol, and triglycerides levels below the P75 percentile, and HDL-c above the P10 percentile. For CT, P75 was: 160mg/dL for the age range of 1 to <3 years, 170mg/dL for ≥3 to <9 years, and 176mg/dL for ≥9 to <13 years. For non-HDL cholesterol, it was 122mg/dL for the age range of 1 to <13 years. For LDL-c, it was 104mg/dL at the age range of 1 to <9 years and 106mg/dL from ≥9 to <13 years. For TG, it was 127mg/dL from 1 to <2 years; 98mg/dL from ≥2 to <6 years; and 92mg/dL from ≥6 to <13 years. As for HDL-cholesterol, P10 was 24mg/dL, 28mg/dL, 32mg/dL, and 36mg/dL, for the age ranges of 1 to <2 years, ≥2 to <3 years, ≥3 to <4 years, and ≥4 to <13 years, respectively. The decision limits for the serum lipid levels defined in this study differed from those observed in the current Brazilian and North-American guidelines, especially because it differentiates between the age ranges. Using these decision limits in clinical practice will certainly contribute to improve the diagnostic accuracy for dyslipidemia in this population group.

Identifiants

pubmed: 29526481
pii: S0021-7557(17)30451-5
doi: 10.1016/j.jped.2018.01.003
pii:
doi:

Substances chimiques

Cholesterol, HDL 0
Cholesterol, LDL 0
Lipids 0
Triglycerides 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

173-179

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.

Auteurs

Natasha Slhessarenko (N)

Universidade Federal de Mato Grosso (UFMT), Faculdade de Medicina, Departamento de Pediatria, Cuiabá, MT, Brazil. Electronic address: ronama@terra.com.br.

Cor J F Fontes (CJF)

Universidade Federal de Mato Grosso (UFMT), Faculdade de Medicina, Departamento de Clínica Médica, Cuiabá, MT, Brazil.

Maria Eduarda Slhessarenko (ME)

Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.

Raymundo S Azevedo (RS)

Universidade de São Paulo (USP), Faculdade de Medicina, São Paulo, SP, Brazil.

Adagmar Andriolo (A)

Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH